Publication

  • 105.

    Takashima E, Otsuki H, Morita M, Ito D, Nagaoka H, Yuguchi T, Hassan I, Tsuboi T.
    The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum.
    Biomolecules. 2024 Jan 12;14(1):100. doi: 10.3390/biom14010100.
    PMID: 38254700

  • 104.

    Kunkeaw N, Nguitragool W, Takashima E, Kangwanrangsan N, Muramatsu H, Tachibana M, Ishino T, Lin PJC, Tam YK, Pichyangkul S, Tsuboi T, Pardi N, Sattabongkot J.
    A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax.
    NPJ Vaccines. 2023 Dec 14;8(1):187. doi: 10.1038/s41541-023-00786-9.
    PMID: 38092803

  • 103.

    Inklaar MR, de Jong RM, Bekkering ET, Nagaoka H, Fennemann FL, Teelen K, van de Vegte-Bolmer M, van Gemert GJ, Stoter R, King CR, Proellochs NI, Bousema T, Takashima E, Tsuboi T, Jore MM.
    Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody.
    NPJ Vaccines. 2023 Dec 12;8(1):186. doi: 10.1038/s41541-023-00784-x.
    PMID: 38086855

  • 102.

    Thongpoon S, Roobsoong W, Nguitragool W, Chotirat S, Tsuboi T, Takashima E, Cui L, Ishino T, Tachibana M, Miura K, Sattabongkot J.
    Naturally Acquired Transmission-Blocking Immunity Against Different Strains of Plasmodium vivax in a Malaria-Endemic Area in Thailand.
    J Infect Dis. 2024 Feb 14;229(2):567-575. doi: 10.1093/infdis/jiad469.
    PMID: 37943633 Free PMC article.

  • 101.

    Hassan I, Kanoi BN, Nagaoka H, Sattabongkot J, Udomsangpetch R, Tsuboi T, Takashima E.
    High-Throughput Antibody Profiling Identifies Targets of Protective Immunity against P. falciparum Malaria in Thailand.
    Biomolecules. 2023 Aug 18;13(8):1267. doi: 10.3390/biom13081267.
    PMID: 37627332

  • 100.

    Ito D, Kondo Y, Takashima E, Iriko H, Thongkukiatkul A, Torii M, Otsuki H.
    Roles of the RON3 C-terminal fragment in erythrocyte invasion and blood-stage parasite proliferation in Plasmodium falciparum.
    Front Cell Infect Microbiol. 2023 Jun 29;13:1197126. doi: 10.3389/fcimb.2023.1197126. eCollection 2023.
    PMID: 37457963

  • 99.

    Yamada K, Soga F, Tokunaga S, Nagaoka H, Ozawa T, Kishi H, Takashima E, Sawasaki T.
    GATS tag system is compatible with biotin labelling methods for protein analysis.
    Sci Rep. 2023 Jun 23;13(1):10243. doi: 10.1038/s41598-023-36858-y.
    PMID: 37353572

  • 98.

    Mazhari R, Takashima E, Longley RJ, Ruybal-Pesantez S, White MT, Kanoi BN, Nagaoka H, Kiniboro B, Siba P, Tsuboi T, Mueller I.
    Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria.
    Front Cell Infect Microbiol. 2023 Jan 25;13:1076150. doi: 10.3389/fcimb.2023.1076150. eCollection 2023.
    PMID: 36761894

  • 97.

    Tebeje SK, Chali W, Hailemeskel E, Ramjith J, Gashaw A, Ashine T, Nebret D, Esayas E, Emiru T, Tsegaye T, Teelen K, Lanke K, Takashima E, Tsuboi T, Salinas ND, Tolia NH, Narum D, Drakeley C, Witkowski B, Vantaux A, Jore MM, Stone WJR, Hansen IS, Tadesse FG, Bousema T.
    Naturally acquired antibodies to gametocyte antigens are associated with reduced transmission of Plasmodium vivax gametocytes to Anopheles arabiensis mosquitoes.
    Front Cell Infect Microbiol. 2023 Jan 16;12:1106369. doi: 10.3389/fcimb.2022.1106369. eCollection 2022.
    PMID: 36726645

  • 96.

    Takashima E, Nagaoka H, Correia R, Alves PM, Roldão A, Christensen D, Guderian JA, Fukushima A, Viebig NK, Depraetere H, Tsuboi T.
    A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies.
    Front Immunol. 2022 Oct 27;13:1002430. doi: 10.3389/fimmu.2022.1002430. eCollection 2022.
    PMID: 36389677